Drug intelligence / Profile preview

circSLCO1B7 siRNA

Development stage
Preclinical
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

circSLCO1B7 siRNA is an experimental small interfering RNA (siRNA) designed to silence the expression of the circular RNA circSLCO1B7. In hepatocellular carcinoma (HCC), circSLCO1B7 has been identified as a tumor suppressor that is frequently downregulated in malignant tissues. It functions as a competitive endogenous RNA (ceRNA) by sponging miR-556-3p, which in turn upregulates the expression of the downstream target gene DAB2IP, thereby inhibiting the epithelial-mesenchymal transition (EMT) and tumor metastasis. The siRNA is used in preclinical research to demonstrate that the loss of circSLCO1B7 promotes cell growth, migration, and invasion, validating the circRNA as a potential therapeutic target for HCC.

Other names
si-circSLCO1B7si-circSLCO-1B7si-circSLCO 1B7
02

Targets

circSLCO1B7 (circular RNA SLCO1B7)

Beyond the preview

Go deeper on circSLCO1B7 siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on circSLCO1B7 siRNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call